186 related articles for article (PubMed ID: 32255415)
1. Clear Cell Renal Cell Carcinoma Growth Correlates with Baseline Diffusion-weighted MRI in Von Hippel-Lindau Disease.
Farhadi F; Nikpanah M; Paschall AK; Shafiei A; Tadayoni A; Ball MW; Linehan WM; Jones EC; Malayeri AA
Radiology; 2020 Jun; 295(3):583-590. PubMed ID: 32255415
[TBL] [Abstract][Full Text] [Related]
2. An MRI-based radiomics model to predict clear cell renal cell carcinoma growth rate classes in patients with von Hippel-Lindau syndrome.
Anari PY; Lay N; Gopal N; Chaurasia A; Samimi S; Harmon S; Firouzabadi FD; Merino MJ; Wakim P; Turkbey E; Jones EC; Ball MW; Turkbey B; Linehan WM; Malayeri AA
Abdom Radiol (NY); 2022 Oct; 47(10):3554-3562. PubMed ID: 35869307
[TBL] [Abstract][Full Text] [Related]
3. Whole-Tumor Quantitative Apparent Diffusion Coefficient Histogram and Texture Analysis to Differentiation of Minimal Fat Angiomyolipoma from Clear Cell Renal Cell Carcinoma.
Li H; Li A; Zhu H; Hu Y; Li J; Xia L; Hu D; Kamel IR; Li Z
Acad Radiol; 2019 May; 26(5):632-639. PubMed ID: 30087067
[TBL] [Abstract][Full Text] [Related]
4. The kidney imaging surveillance scoring system (KISSS): using qualitative MRI features to predict growth rate of renal tumors in patients with von-Hippel Lindau (VHL) syndrome.
Gopal N; Anari PY; Chaurasia A; Antony M; Wakim P; Linehan WM; Ball M; Turkbey E; Malayeri A
Abdom Radiol (NY); 2024 Feb; 49(2):542-550. PubMed ID: 38010527
[TBL] [Abstract][Full Text] [Related]
5. Growth characteristics and therapeutic decision markers in von Hippel-Lindau disease patients with renal cell carcinoma.
Schuhmacher P; Kim E; Hahn F; Sekula P; Jilg CA; Leiber C; Neumann HP; Schultze-Seemann W; Walz G; Zschiedrich S
Orphanet J Rare Dis; 2019 Oct; 14(1):235. PubMed ID: 31661010
[TBL] [Abstract][Full Text] [Related]
6. Kidney tumor diffusion-weighted magnetic resonance imaging derived ADC histogram parameters combined with patient characteristics and tumor volume to discriminate oncocytoma from renal cell carcinoma.
van Oostenbrugge TJ; Spenkelink IM; Bokacheva L; Rusinek H; van Amerongen MJ; Langenhuijsen JF; Mulders PFA; Fütterer JJ
Eur J Radiol; 2021 Dec; 145():110013. PubMed ID: 34768055
[TBL] [Abstract][Full Text] [Related]
7. Grading Clear Cell Renal Cell Carcinoma Grade Using Diffusion Relaxation Correlated MR Spectroscopic Imaging.
Dai Y; Hu W; Wu G; Wu D; Zhu M; Luo Y; Wang J; Zhou Y; Hu P
J Magn Reson Imaging; 2024 Feb; 59(2):699-710. PubMed ID: 37209407
[TBL] [Abstract][Full Text] [Related]
8. Can diffusion-weighted magnetic resonance imaging of clear cell renal carcinoma predict low from high nuclear grade tumors.
Parada Villavicencio C; Mc Carthy RJ; Miller FH
Abdom Radiol (NY); 2017 Apr; 42(4):1241-1249. PubMed ID: 27904923
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Biexponential and Monoexponential Model of Diffusion-Weighted Imaging for Distinguishing between Common Renal Cell Carcinoma and Fat Poor Angiomyolipoma.
Ding Y; Zeng M; Rao S; Chen C; Fu C; Zhou J
Korean J Radiol; 2016; 17(6):853-863. PubMed ID: 27833401
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic test accuracy of ADC values for identification of clear cell renal cell carcinoma: systematic review and meta-analysis.
Tordjman M; Mali R; Madelin G; Prabhu V; Kang SK
Eur Radiol; 2020 Jul; 30(7):4023-4038. PubMed ID: 32144458
[TBL] [Abstract][Full Text] [Related]
11. Monoexponential, biexponential, and stretched exponential diffusion-weighted imaging models: Quantitative biomarkers for differentiating renal clear cell carcinoma and minimal fat angiomyolipoma.
Li H; Liang L; Li A; Hu Y; Hu D; Li Z; Kamel IR
J Magn Reson Imaging; 2017 Jul; 46(1):240-247. PubMed ID: 27859853
[TBL] [Abstract][Full Text] [Related]
12. Comparison of biexponential and monoexponential DWI in evaluation of Fuhrman grading of clear cell renal cell carcinoma.
Shen L; Zhou L; Liu X; Yang X
Diagn Interv Radiol; 2017; 23(2):100-105. PubMed ID: 28050950
[TBL] [Abstract][Full Text] [Related]
13. Differentiating papillary type I RCC from clear cell RCC and oncocytoma: application of whole-lesion volumetric ADC measurement.
Paschall AK; Mirmomen SM; Symons R; Pourmorteza A; Gautam R; Sahai A; Dwyer AJ; Merino MJ; Metwalli AR; Linehan WM; Malayeri AA
Abdom Radiol (NY); 2018 Sep; 43(9):2424-2430. PubMed ID: 29520425
[TBL] [Abstract][Full Text] [Related]
14. Subtype Differentiation of Small (≤ 4 cm) Solid Renal Mass Using Volumetric Histogram Analysis of DWI at 3-T MRI.
Li A; Xing W; Li H; Hu Y; Hu D; Li Z; Kamel IR
AJR Am J Roentgenol; 2018 Sep; 211(3):614-623. PubMed ID: 29812980
[TBL] [Abstract][Full Text] [Related]
15. Germline VHL gene variant in patients with von Hippel-Lindau disease does not predict renal tumor growth.
Farhadi F; Nikpanah M; Li X; Symons R; Pourmorteza A; Merino MJ; Linehan WM; Malayeri AA
Abdom Radiol (NY); 2018 Oct; 43(10):2743-2749. PubMed ID: 29525880
[TBL] [Abstract][Full Text] [Related]
16. Diffusion weighted and dynamic contrast enhanced MRI as an imaging biomarker for stereotactic ablative body radiotherapy (SABR) of primary renal cell carcinoma.
Reynolds HM; Parameswaran BK; Finnegan ME; Roettger D; Lau E; Kron T; Shaw M; Chander S; Siva S
PLoS One; 2018; 13(8):e0202387. PubMed ID: 30114235
[TBL] [Abstract][Full Text] [Related]
17. Utility of the apparent diffusion coefficient for distinguishing clear cell renal cell carcinoma of low and high nuclear grade.
Rosenkrantz AB; Niver BE; Fitzgerald EF; Babb JS; Chandarana H; Melamed J
AJR Am J Roentgenol; 2010 Nov; 195(5):W344-51. PubMed ID: 20966299
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Monoexponential, Biexponential, Stretched-Exponential, and Kurtosis Models of Diffusion-Weighted Imaging in Differentiation of Renal Solid Masses.
Zhang J; Suo S; Liu G; Zhang S; Zhao Z; Xu J; Wu G
Korean J Radiol; 2019 May; 20(5):791-800. PubMed ID: 30993930
[TBL] [Abstract][Full Text] [Related]
19. Systemic treatment of the metastatic renal cell carcinoma: usefulness of the apparent diffusion coefficient of diffusion-weighted MRI in prediction of early therapeutic response.
Mytsyk Y; Pasichnyk S; Dutka I; Dats I; Vorobets D; Skrzypczyk M; Uteuliyev Y; Botikova A; Gazdikova K; Kubatka P; Urdzik P; Kruzliak P
Clin Exp Med; 2020 May; 20(2):277-287. PubMed ID: 32026157
[TBL] [Abstract][Full Text] [Related]
20. Growth kinetics in von Hippel-Lindau-associated renal cell carcinoma.
Jilg CA; Neumann HP; Gläsker S; Schäfer O; Ardelt PU; Schwardt M; Schultze-Seemann W
Urol Int; 2012; 88(1):71-8. PubMed ID: 22156657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
